Sword Health nabs $40M at $4B valuation, pushes IPO plans to at least 2028
The digital health startup says it secured the fresh capital to update its valuation and finance acquisitions.
The digital health startup says it secured the fresh capital to update its valuation and finance acquisitions.
23andMe holds millions of customers' genetic information. Here's what you can do to protect your data.
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research Institute, a nonprofit led by the company's co-founder and former CEO Anne Wojcicki.